GUIDED THERAPEUTICS INC Quarterly Interest Expense in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Guided Therapeutics Inc quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q2 2024.
  • Guided Therapeutics Inc Interest Expense for the quarter ending June 30, 2024 was $75K, a 8.7% increase year-over-year.
  • Guided Therapeutics Inc Interest Expense for the twelve months ending June 30, 2024 was $282K, a 21.7% decline year-over-year.
  • Guided Therapeutics Inc annual Interest Expense for 2023 was $278K, a 52.2% decline from 2022.
  • Guided Therapeutics Inc annual Interest Expense for 2022 was $582K, a 49.4% decline from 2021.
  • Guided Therapeutics Inc annual Interest Expense for 2021 was $1.15M, a 8.9% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $282K $75K +$6K +8.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $276K $64K -$2K -3.03% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $278K $72K +$2K +2.86% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $276K $71K -$84K -54.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $360K $69K -$187K -73% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $547K $66K -$35K -34.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $582K $70K -$30K -30% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $612K $155K -$439K -73.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $1.05M $256K -$59K -18.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.11M $101K -$40K -28.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $1.15M $100K -$44K -30.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.19M $594K +$277K +87.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $917K $315K +$7K +2.27% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $910K $141K -$146K -50.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $1.06M $144K -$257K -64.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $1.31M $317K -$59K -15.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $1.37M $308K +$44K +16.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-18
Q1 2020 $1.33M $287K -$84K -22.6% Jan 1, 2020 Mar 31, 2020 10-Q/A 2021-08-18
Q4 2019 $1.41M $401K -$583K -59.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-07
Q3 2019 $2M $376K +$137K +57.3% Jul 1, 2019 Sep 30, 2019 10-Q/A 2020-11-05
Q2 2019 $1.86M $264K -$32K -10.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-20
Q1 2019 $1.89M $371K +$127K +52% Jan 1, 2019 Mar 31, 2019 10-Q 2020-07-07
Q4 2018 $1.76M $984K +$694K +239% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-20
Q3 2018 $1.07M $239K -$29K -10.8% Jul 1, 2018 Sep 30, 2018 10-Q 2020-03-09
Q2 2018 $1.1M $296K -$29K -8.92% Apr 1, 2018 Jun 30, 2018 10-Q 2020-02-11
Q1 2018 $1.13M $244K +$21K +9.42% Jan 1, 2018 Mar 31, 2018 10-Q 2019-07-11
Q4 2017 $1.11M $290K -$8K -2.69% Oct 1, 2017 Dec 31, 2017 10-K 2019-05-08
Q3 2017 $1.11M $268K +$42K +18.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.07M $325K -$888K -73.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $1.96M $223K +$65K +41.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 $1.9M $298K +$200K +204% Oct 1, 2016 Dec 31, 2016 10-K/A 2018-04-20
Q3 2016 $1.7M $226K -$178K -44.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 $1.87M $1.21M +$890K +276% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-18
Q1 2016 $983K $158K -$334K -67.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-22
Q4 2015 $1.32M $98K -$436K -81.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-22
Q3 2015 $1.75M $404K +$33K +8.9% Jul 1, 2015 Sep 30, 2015 10-Q 2016-12-05
Q2 2015 $1.72M $323K +$276K +587% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-17
Q1 2015 $1.44M $492K +$465K +1722% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-19
Q4 2014 $979K $534K +$524K +5240% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 $455K $371K +$360K +3273% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $95K $47K +$38K +422% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $57K $27K +$12K +80% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 $45K $10K -$10K -50% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-25
Q3 2013 $55K $11K -$5K -31.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $60K $9K -$10K -52.6% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $70K $15K -$2K -11.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 $72K $20K +$2K +11.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-26
Q3 2012 $70K $16K -$5K -23.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $75K $19K +$1K +5.56% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $74K $17K -$6K -26.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 $80K $18K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-27
Q3 2011 $21K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $18K +$46K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-24
Q1 2011 $23K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q2 2010 -$28K Apr 1, 2010 Jun 30, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.